p53 in the anticancer mechanism of vitamin E

European Journal of Cancer. Part B: Oral Oncology

Volumn 29, Issue 4, 1993, Pages 313-318

  Schwartz, Joel ^a   Shklar, Gerald ^a   Trickler, Diane ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CHEEK POUCH; CONTROLLED STUDY; HAMSTER; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMAL; ANTIBODIES, MONOCLONAL; CHEMOPREVENTION; DNA MUTATIONAL ANALYSIS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HAMSTERS; IMMUNOHISTOCHEMISTRY; MALE; MESOCRICETUS; MOUTH NEOPLASMS; NEOPLASMS, EXPERIMENTAL; VITAMIN E;

EID: 0027331336     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(93)90055-J     Document Type: Article

References (65)

1. The nuclear oncoproteins: RB and p53
2. Mutations in the p53 gene occur in diverse human tumor types
3. Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors
4. p53 expression in breast cancer
5. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
6. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer
7. p53: a frequent target for genetic abnormalities in lung cancer
8. Increased expression of mutant forms of p53 oncogene in primary lung cancer
9. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
10. Expression of the nuclear oncogene p53 in colon tumors
11. p53 mutations in colorectal cancer
12. Chromosome 17 deletion and p53 gene mutation in colorectal tumors
13. p53 gene mutation in gastric cancer metastases and in gastric cancer cell lines derived from metastases
14. Expression of the tumor suppression gene p53 in oral cancer
15. Expression of p53 in premalignant and malignant squamous epithelium
16. Rearrangement of the p53 gene in human osteogenic sarcomas
17. Activation of c-erb B oncogene in the hamster cheek pouch during DMBA-induced carcinogenesis
18. Detection of Ki-ras mRNA in normal and chemically transformed hamster oral keratinocytes
19. Sequential expression and cooperative interaction of c-Ha-ras and c-erb B genes in in vivo chemical carcinogenesis
20. Oncogene activation in squamous cell carcinoma of the oral cavity
21. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck
22. Frequent p53 mutations in head and neck cancer
23. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
24. T-Antigen is bound to a host protein in SV40 transformed cells
25. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
26. Cooperation between gene encoding p53 tumor antigen and ras in cellular transformation
27. Inactivation of the p53 oncogene by internal delection or retroviral intergration in erythroleukemic cell lines induced by Friend leukemia virus
28. Widetype p53 can inhibit oncogene-mediated focus formation
29. The p53 proto-oncogene can act as a suppressor of transformation
30. Safety of oral intake of vitamin E
31. Dimethylbenzanthracene-induced cancer. Inhibiting effect of dietary vitamin E
32. Inhibition of oral mucosal carcinogenesis by vitamin E
33. Retardation of experimental oral cancer by topical vitamin E
34. Prevention by vitamin E of oral carcinogenesis
35. Regression by vitamin E of experimental oral cancer
36. Prevention of experimental cancer and immunostimulation by vitamin E. (Immunosurveillance)
37. Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta carotene and algae extract
38. Alpha tocopherol alters the distribution of Langerhans cells in DMBA treated hamster cheek pouch epithelium
39. Vitamin E as an anticarcinogen
40. Regression of experimental cancer by oral administration of combined alpha tocopherol and beta carotene
41. Serum beta carotene vitamins E and A selenium and the risk of lung cancer
42. Plasma levels of antioxidants β-carotene and α-tocopherol in uterine cervix dysplasia and cancer
43. Experimental carcinogenesis in the cheek pouch of the Syrian hamster
44. Factors influencing experimental carcinogenesis in the hamster cheek pouch
45. The effect of a carcinogen (DMBA) applied to the hamster's buccal pouch in combination with croton oil
46. The histochemistry of experimentally induced leukoplakia and carcinoma of the hamster buccal pouch
47. Experimental oral pathology in the Syrian hamster
48. Selective cytotoxicity activity of carotenoids and alpha tocopherol on human carcinoma cells
49. Activating mutations for transforming by p53 produce a gene product that forms an hsp 70-p53 complex with an altered half life
50. Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells
51. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines
52. Carotenoids up-regulate connexin-43 gene expression independent of their protein A or antioxidant properties
53. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer cheomtherapy compounds in differentiation-competent and defective myeloid leukemic cells
54. Wild type-p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6
55. Oral cancer inhibition by micronutrients. The experimental basis for clinical trials
56. Biochemical events and relevance to cancer chemotherapy. Apoptosis
57. p53 guardian of the genome
58. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion
59. Regulation of heat shock factor primer formation: role of a conserved leucine zipper
60. Transcription of the human hsp 70 gene is induced by serum stimulation
61. Intracellular thiols regulate activation of nuclear factor kB and transcription of human immunodeficiency virus
62. Diseases associated with HTLV-1 virus, IL-2 receptor dysregulation and redox regulation
63. Effect of vitamin E succinate and cAMP-stimulating agent on the expression of c-myc, N-myc, and H-ras in murine neuroblastoma cells
64. Differences in the effect of vitamin E on nickel sulfide or nickel chloride-induced chromosomal aberrations in mammalian cells
65. Regulation of the human hsp 70 promoter by p53